PD
Point72 (DIFC) Portfolio holdings
AUM $1.25B
1-Year Return
9.31%
This Quarter Return
+5.32%
1 Year Return
+9.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.25B
AUM Growth
+$216M
(+21%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
12.56%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
1,672
New
551
Increased
173
Reduced
205
Closed
545
Top Buys
| 1 |
GE Aerospace
GE
|
+$22.9M |
| 2 |
Philip Morris
PM
|
+$22M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$21.3M |
| 4 |
CRH
CRH
|
+$19.2M |
| 5 |
Banco Bradesco
BBD
|
+$18.9M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$29.6M |
| 2 |
Cisco
CSCO
|
+$17.8M |
| 3 |
Qiagen
QGEN
|
+$14M |
| 4 |
Coca-Cola
KO
|
+$13.7M |
| 5 |
Steris
STE
|
+$13.4M |
Sector Composition
| 1 | Healthcare | 28.96% |
| 2 | Technology | 22.18% |
| 3 | Financials | 12.68% |
| 4 | Industrials | 10.17% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Generation Bio
GBIO
$40.1M
| $463 | ﹤0.01% |
+145
| New | +$463 |
|
902
Tenaya Therapeutics
TNYA
$199M
| $462 | ﹤0.01% |
756
-10,272
| -93% | -$6.28K |
|
903
Cellebrite
CLBT
$4.22B
| $461 | ﹤0.01% |
+29
| New | +$461 |
|
904
Nutanix
NTNX
$20.8B
| $459 | ﹤0.01% |
6
-9,841
| -100% | -$753K |
|
905
Werewolf Therapeutics
HOWL
$64M
| $439 | ﹤0.01% |
+403
| New | +$439 |
|
|
IGMS
906
DELISTED
IGM Biosciences
IGMS
| $435 | ﹤0.01% |
388
-456
| -54% | -$511 |
|
907
Ovid Therapeutics
OVID
$81.1M
| $429 | ﹤0.01% |
+1,301
| New | +$429 |
|
908
Galectin Therapeutics
GALT
$283M
| $395 | ﹤0.01% |
+187
| New | +$395 |
|
909
Cardlytics
CDLX
$81.5M
| $374 | ﹤0.01% |
227
-2,579
| -92% | -$4.25K |
|
910
Purple Innovation
PRPL
$114M
| $362 | ﹤0.01% |
+497
| New | +$362 |
|
|
TPIC
911
DELISTED
TPI Composites
TPIC
| $356 | ﹤0.01% |
+414
| New | +$356 |
|
912
Destination XL Group
DXLG
$76.5M
| $328 | ﹤0.01% |
+295
| New | +$328 |
|
913
Diamondback Energy
FANG
$40.1B
| $322 | ﹤0.01% |
2
-81,088
| -100% | -$13.1M |
|
|
CTNM
914
Contineum Therapeutics
CTNM
$333M
| $258 | ﹤0.01% |
+65
| New | +$258 |
|
915
MacroGenics
MGNX
$92.9M
| $230 | ﹤0.01% |
+190
| New | +$230 |
|
916
Inotiv
NOTV
$46.4M
| $229 | ﹤0.01% |
+126
| New | +$229 |
|
917
Metagenomi
MGX
$68.7M
| $198 | ﹤0.01% |
+134
| New | +$198 |
|
918
Quest Resource Holding
QRHC
$32.5M
| $192 | ﹤0.01% |
+95
| New | +$192 |
|
919
Shore Bancshares
SHBI
$563M
| $110 | ﹤0.01% |
7
-289
| -98% | -$4.54K |
|
920
National Healthcare
NHC
$1.79B
| $107 | ﹤0.01% |
+1
| New | +$107 |
|
921
Mercer International
MERC
$212M
| $105 | ﹤0.01% |
30
-889
| -97% | -$3.11K |
|
922
Tilray
TLRY
$1.33B
| $104 | ﹤0.01% |
+255
| New | +$104 |
|
923
374Water
SCWO
$50.1M
| $98 | ﹤0.01% |
+302
| New | +$98 |
|
924
American Vanguard Corp
AVD
$159M
| $94 | ﹤0.01% |
24
-3,314
| -99% | -$13K |
|
925
Design Therapeutics
DSGN
$333M
| $66 | ﹤0.01% |
+20
| New | +$66 |
|